Replimune Group, Inc. (REPL)
NASDAQ·Healthcare·Biotechnology
$21.86
—
Mkt Cap $1.96B
Analyst Ratings
Buy
7
Hold
4
Sell
0
Price Target (21 analysts)
$18.67
Range $17.00 – $20.00
Implied Upside
-14.6%
Consensus $18.67 vs current $21.86
NASDAQ·Healthcare·Biotechnology
$21.86
—
Mkt Cap $1.96B
Buy
7
Hold
4
Sell
0
Price Target (21 analysts)
$18.67
Range $17.00 – $20.00
-14.6%
Consensus $18.67 vs current $21.86